Home
About
- About Molecure S.A.
- Our Team
R&D
Research Partnerships
- In-licensing
- Commercial Partnership
Investors
News & Events
- Press Releases
- Events & Presentations
Careers
Contact

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.

This site is registered on wpml.org as a development site.